Chemotherapy for clinical stage I nonseminomatous germ cell tumours.

Abstract

In 2008, ≈ 8000 American men were diagnosed with testicular cancer [1]; about half of these patients will have nonseminomatous germ cell tumours (NSGCT). Of these, about half will present with clinical stage (CS) I disease [2], defined as disease localized to the testis with normal serum tumour markers ( α -fetoprotein and hCG) after orchidectomy and no… (More)
DOI: 10.1111/j.1464-410X.2009.08863.x

Topics

3 Figures and Tables

Cite this paper

@article{Vaughn2009ChemotherapyFC, title={Chemotherapy for clinical stage I nonseminomatous germ cell tumours.}, author={David J. Vaughn}, journal={BJU international}, year={2009}, volume={104 9 Pt B}, pages={1381-6} }